Jessie Benson1, Cameron Severn2, Julia Hudnut-Beumler3, Stacey L Simon4, Natalie Abramson1, Lauren B Shomaker5, Lauren D Gulley5, Anya Taylor1, Megan M Kelsey6, Kristen J Nadeau6, Philip S Zeitler1, Laura Pyle7, Melanie Cree-Green8. 1. Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. 2. Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado, United States. 3. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. 4. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States; Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. 5. Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States; Department of Human Development and Family Studies, Colorado State University, Fort Collins, Colorado, United States. 6. Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States; Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. 7. Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, Colorado, United States; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. 8. Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States; Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States. Electronic address: melanie.green@childrenscolorado.org.
Abstract
OBJECTIVES: Polycystic ovary syndrome (PCOS) is a common reproductive/metabolic condition associated with obesity, type 2 diabetes (T2D) and depression in adult women. Depression in adults is related to PCOS dermatologic manifestations. Adolescents with obesity with or without T2D have elevated depression symptoms, but data from youth with PCOS and obesity with/without T2D are limited. METHODS: Our study included girls, aged 11 to 17 years, with obesity and PCOS, PCOS+T2D or T2D, who were newly seen in an obesity complications clinic after March 2016. All participants had Center for Epidemiologic Studies-Depression (CES-D, 20 items) scores obtained within 6 months of PCOS or T2D diagnosis. Data on history of psychiatric diagnosis and treatment, metabolic syndrome and severity of acne and hirsutism were collected through chart review. RESULTS: One hundred five girls (47 with PCOS, 14 with PCOS+T2D, 44 with T2D) had similar age (15±1.8 years) and body mass index z scores (2.2±0.4). CES-D scores ≥16, indicating elevated depression symptoms, and CES-D scores ≥24, indicating severe depression symptoms, were observed in 60% and 30% of girls with PCOS, 78% and 71% of those with PCOS+T2D and 39% and 21% of those with T2D, respectively (p<0.0001 for both cutpoints). A higher CES-D score was not associated with severity of hirsutism or acne (p>0.05 for both). CONCLUSIONS: Adolescents with PCOS and obesity have higher rates of elevated depression symptoms compared with girls with T2D, which is not related to worse dermatologic symptoms. Because depression may impact both PCOS and T2D management and adherence to therapy, greater efforts should be made to screen for and address mental health in adolescents with PCOS and obesity, especially if T2D is present.
OBJECTIVES:Polycystic ovary syndrome (PCOS) is a common reproductive/metabolic condition associated with obesity, type 2 diabetes (T2D) and depression in adult women. Depression in adults is related to PCOS dermatologic manifestations. Adolescents with obesity with or without T2D have elevated depression symptoms, but data from youth with PCOS and obesity with/without T2D are limited. METHODS: Our study included girls, aged 11 to 17 years, with obesity and PCOS, PCOS+T2D or T2D, who were newly seen in an obesity complications clinic after March 2016. All participants had Center for Epidemiologic Studies-Depression (CES-D, 20 items) scores obtained within 6 months of PCOS or T2D diagnosis. Data on history of psychiatric diagnosis and treatment, metabolic syndrome and severity of acne and hirsutism were collected through chart review. RESULTS: One hundred five girls (47 with PCOS, 14 with PCOS+T2D, 44 with T2D) had similar age (15±1.8 years) and body mass index z scores (2.2±0.4). CES-D scores ≥16, indicating elevated depression symptoms, and CES-D scores ≥24, indicating severe depression symptoms, were observed in 60% and 30% of girls with PCOS, 78% and 71% of those with PCOS+T2D and 39% and 21% of those with T2D, respectively (p<0.0001 for both cutpoints). A higher CES-D score was not associated with severity of hirsutism or acne (p>0.05 for both). CONCLUSIONS: Adolescents with PCOS and obesity have higher rates of elevated depression symptoms compared with girls with T2D, which is not related to worse dermatologic symptoms. Because depression may impact both PCOS and T2D management and adherence to therapy, greater efforts should be made to screen for and address mental health in adolescents with PCOS and obesity, especially if T2D is present.
Keywords:
adolescentes; adolescents; depression; diabète de type 2; dépression; polycystic ovary syndrome; syndrome des ovaires polykystiques; type 2 diabetes
Authors: Casey S Hopkins; Laura P Kimble; Helen F Hodges; Anne F Koci; Benjie B Mills Journal: J Am Assoc Nurse Pract Date: 2019-03 Impact factor: 1.165
Authors: Barbara J Anderson; Sharon Edelstein; Natalie Walders Abramson; Lorraine E Levitt Katz; Patrice M Yasuda; Sylvia J Lavietes; Paula M Trief; Sherida E Tollefsen; Siripoom Vudhipoom McKay; Patricia Kringas; Terri Lynn Casey; Marsha D Marcus Journal: Diabetes Care Date: 2011-08-11 Impact factor: 19.112
Authors: Ju Ryoung Moon; June Huh; Jinyoung Song; I-Seok Kang; Seung Woo Park; Sung-A Chang; Ji-Hyuk Yang; Tae-Gook Jun Journal: Health Qual Life Outcomes Date: 2017-09-05 Impact factor: 3.186
Authors: Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt Journal: J Clin Endocrinol Metab Date: 2013-10-22 Impact factor: 5.958
Authors: C Torres-Zegarra; D Sundararajan; J Benson; H Seagle; M Witten; N Walders-Abramson; S L Simon; P Huguelet; N J Nokoff; M Cree-Green Journal: J Pediatr Adolesc Gynecol Date: 2021-03-29 Impact factor: 2.046